Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)

Name: Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)
License: Public Domain

Shanghai Changzheng Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

colorectal cancer, immunotherapy, anlotinib, sintilimab, chemo-free therapy, first-line treatment

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272352
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.